<i>KEAP1/NFE2L2</i> Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase InhibitionMichael S. Binkley, Maximilian Diehn, Christopher H. Yoo et al.|Cancer Discovery|2020Cited by 172
STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-κB to IL-6 Signaling Axis and STAT3-Driven Cancer PhenotypesMichael Xiang, David A. Frank|Science Signaling|2014Cited by 166
Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agentMichael Xiang, David A. Frank|Blood|2016Cited by 113
Targeting constitutively active <scp>STAT3</scp> in chronic lymphocytic leukemia: A clinical trial of the <scp>STAT3</scp> inhibitor pyrimethamine with pharmacodynamic analysesJennifer R. Brown, David A. Frank, Sarah R. Walker et al.|American Journal of Hematology|2020Cited by 29